Latest News

CardiacAssist expands market penetration of TandemHeart

Gore Announces First Implant of Next Generation Conformable GORE TAG

Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc

Cook Sues Endologix For Patent Infringement Over Aortic Aneurysm Endograft Technology

New Endovascular Graft for Thoracic Aortic Aneurysm Used in Australia for the First Time

BioControl Medical cordially invites you to attend a presentation on: Chronic Vagus Nerve Stimulation in Patients with Heart Failure Potential Predictors of Success

Unetixs Vascular Forms Strategic Alliance with Endothelix To Commercialize Significantly Improved Cardiovascular Diagnostic Technology

CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex

MAQUET CARDIOVASCULAR RECEIVES FDA CLEARANCE FOR MEGA(TM), THE WORLD'S FIRST 8Fr. 50cc INTRA-AORTIC BALLOON CATHETER

More news... | RSS Feed...

Most Viewed

Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex

Cook Sues Endologix For Patent Infringement Over Aortic Aneurysm Endograft Technology

CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves

Unetixs Vascular Forms Strategic Alliance with Endothelix To Commercialize Significantly Improved Cardiovascular Diagnostic Technology

MAQUET CARDIOVASCULAR RECEIVES FDA CLEARANCE FOR MEGA(TM), THE WORLD'S FIRST 8Fr. 50cc INTRA-AORTIC BALLOON CATHETER

BioControl Medical cordially invites you to attend a presentation on: Chronic Vagus Nerve Stimulation in Patients with Heart Failure Potential Predictors of Success

New Endovascular Graft for Thoracic Aortic Aneurysm Used in Australia for the First Time

Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery

BioInvent updates on the progress of the Phase II trial of the long acting anticoagulant TB-402

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire